VISEN PHARMACEUTICALS
VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living better lives. Putting patients’ need first, VISEN is committed to providing first-in-class or best-in-class products and treatments for endocrine diseases. Our therapeutic areas cover endocrine diseases in adults and children, and rar... e endocrine diseases. VISEN comprises seasoned professionals with multinational pharmaceutical experiences and leverages cutting-edge technologies and leading resources across the world. We are focused on the Chinese market, and have established offices in Shanghai, Beijing, Hong Kong and Taipei. We have also launched our Greater China R&D and manufacturing site in Suzhou to enhance R&D, manufacturing and commercialization efforts. Our goal is to enable Chinese endocrine patients to benefit from the world's most advanced and reliable treatment solutions earlier.
VISEN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-11-07
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.visenpharma.com
Total Employee:
101+
Status:
Active
Contact:
+86 021 5299 9605
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro SPF Mobile Non Scaleable Content Apache Pound Sterling Microsoft Azure DNS PHP
Similar Organizations
Alebund Pharmaceuticals
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
Artiva Biotherapeutics
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a privately-held biotech company focused on the development and commercialization of innovative cures for cancer.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
I-Mab Biopharma
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
InxMed
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ascendis Pharma
Ascendis Pharma investment in Series B - Visen Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Visen Pharmaceuticals
Sequoia Capital China
Sequoia Capital China investment in Series B - Visen Pharmaceuticals
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Visen Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series B - Visen Pharmaceuticals
Logos Capital
Logos Capital investment in Series B - Visen Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series B - Visen Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Visen Pharmaceuticals
CDG Capital
CDG Capital investment in Series B - Visen Pharmaceuticals
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Series B - Visen Pharmaceuticals
Official Site Inspections
http://www.visenpharma.com Semrush global rank: 9.86 M Semrush visits lastest month: 300
- Host name: 47.96.72.176
- IP address: 47.96.72.176
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Visen Pharmaceuticals"
VISEN Pharmaceuticals_Emerging Expert in Endocrinology
We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living …See details»
VISENPharmaceuticals_CompanyOverview
VISEN comprises seasoned professionals with multinational pharmaceutical experiences and leverages cutting-edge technologies and leading resources across the world. We are focused …See details»
Visen Pharmaceuticals - Crunchbase Company Profile …
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs. Shanghai, Shanghai, China. 101-250. Series B. Private. www.visenpharma.com/ 145,077. Total Funding …See details»
VISENPharmaceuticals_VisionAndMission
Vision And Mission Every endocrine patient can live life to the fullest with innovative therapies and compassionate care. Achieve better treatment processes and outcomes for endocrine patients …See details»
VISEN Pharmaceuticals Company Profile | Management and
VISEN Pharmaceuticals is committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into the China market and hoping to provide …See details»
VISEN Pharmaceuticals - LinkedIn
About us. VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we...See details»
Visen Pharmaceuticals - PitchBook
Description. Developer of biotechnology and endocrinology intended to provide endocrine treatment solutions and drugs. The company focuses on developing and commercializing innovative endocrine drugs that address significant …See details»
Visen Pharmaceuticals - Craft
Visen Pharmaceuticals (also known as VISEN Pharma) is a biotechnology company that develops treatment methods and drugs for endocrine-related diseases. It aims to address significant …See details»
Visen Pharma - HBM Partners
VISEN Pharmaceuticals, formed by Ascendis Pharma in 2018, is committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market. Back.See details»
VISEN Pharmaceuticals - Overview, News & Similar companies
View VISEN Pharmaceuticals (www.visenpharma.com) location in China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
VISENPharmaceuticals_Leadership
VISEN comprises seasoned professionals with multinational pharmaceutical experiences and leverages cutting-edge technologies and leading resources across the world. We are focused …See details»
VISEN Pharmaceuticals announced that the Phase 3 PaTHway …
Aug 12, 2024 · VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, today announced topline data from the 26-week randomized, double …See details»
VISEN Announces Acceptance of a Biologics License Application …
SHANGHAI, March 7, 2024 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the …See details»
VISEN Announces Acceptance of a Biologics License Application …
Mar 8, 2024 · VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the Biologics License Application (BLA) …See details»
VISEN Pharmaceuticals Closes $150 Million Series B Financing to ...
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet …See details»
VISENPharmaceuticals_ContactUs
VISEN Pharmaceuticals, Emerging Expert in Endocrinology Achieving better treatment processes and outcomes by combining global expertise and strength in endocrine therapiesSee details»
Visen Pharmaceuticals - VentureRadar
Website: http://www.visenpharma.com/ Offers advanced endocrine-related disease treatments and medications in the China market, aiming to provide patients with quick access to reliable …See details»
VISEN Pharmaceuticals announced that the Phase 3 PaTHway
Aug 12, 2024 · VISEN Pharmaceuticals has been granted exclusive rights to develop, manufacture, and commercialize palopegteriparatide (TransCon PTH) in Greater China by …See details»
VISENPharmaceuticals_News
(Mar 8th, 2024, Shanghai, China) - VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the …See details»
台灣維昇藥業-致力推動創新療法，讓內分泌患者能盡情實現對生命 …
台灣維昇藥業VISEN Pharma專注於內分泌及罕見疾病領域，使用創新TransCon技術平台發展新藥，來解決臨床上長久未能被滿足的需求，包含生長激素缺乏症growth hormone deficiency、副 …See details»